Home / Inspections / 860789

FDA Inspection 860789 — SPI Pharma, Inc.

SPI Pharma, Inc. — FEI 1833292

The FDA completed an inspection of SPI Pharma, Inc. on November 19, 2013 in Grand Haven, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 19, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Haven, MI (United States)

Facility

Other inspections at this facility

  • 1291622 (NAI Fri Sep 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1090151 (NAI Mon Apr 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1003696 (NAI Mon Mar 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 729481 (NAI Wed May 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 662416 (NAI Wed May 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources